Research Articles | Page 12 | Aplastic Anemia & MDS International Foundation

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
MDS/MPN-RS-T Justified Inclusion as a Unique Disease Entity? Jun 2020 Best practice & research. Clinical haematology myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPN)
Establishing Specific Response Criteria for MDS/MPN - Getting Closer to Reality? Jun 2020 Best practice & research. Clinical haematology myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPN)
Clonal Hematopoiesis and therapy related MDS/AML Mar 2019 Best Practice & Research. Clinical Heamatology myelodysplastic syndromes (MDS)
Unveiling the paradoxical nature of myelodysplastic syndromes (MDS): Why hypercellular marrow strongly favors accelerated apoptosis. Mar 2013 Biochem Cell Biol myelodysplastic syndromes (MDS)
Eculizumab: a guide to its use in paroxysmal nocturnal hemoglobinuria Apr 2012 BioDrugs paroxysmal nocturnal hemoglobinuria (PNH)
Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes - Lingering Uncertainties and Emerging Possibilities Jul 2014 Biol Blood Marrow Transplant myelodysplastic syndromes (MDS)
Excellent Outcome of Haploidentical Hematopoietic Stem Cell Transplantation in Children and Adolescents with Acquired Severe Aplastic Anemia Feb 2013 Biol Blood Marrow Transplant aplastic anemia
Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation Achieved Outcomes Comparable With Matched Unrelated Donor Transplantation in Young Acquired Severe Aplastic Anemia May 2018 Biol Blood Marrow Transplant acute myeloid leukemia (AML)
The Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) Predicts Outcomes in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes Receiving CD34+ Selected Grafts for Allogeneic Hematopoietic Cell Transplantation Oct 2016 Biol Blood Marrow Transplant myelodysplastic syndromes (MDS)
Long-term outcome of fludarabine-based reduced intensity allogeneic hematopoietic cell transplantation for debilitating paroxysmal nocturnal hemoglobinuria May 2014 Biol Blood Marrow Transplant paroxysmal nocturnal hemoglobinuria (PNH)